Andrew Murphy - May 16, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Andrew Murphy
Stock symbol
REGN
Transactions as of
May 16, 2022
Transactions value $
-$4,746,249
Form type
4
Date filed
5/18/2022, 04:05 PM
Previous filing
Feb 16, 2022
Next filing
Aug 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $1.79M +10K +17.1% $179.13* 68.5K May 16, 2022 Direct F1
transaction REGN Common Stock Tax liability -$4.19M -6.46K -9.43% $648.31 62K May 16, 2022 Direct F1
transaction REGN Common Stock Sale -$38.7K -59 -0.1% $655.40 62K May 17, 2022 Direct F1
transaction REGN Common Stock Sale -$38.1K -58 -0.09% $656.52 61.9K May 17, 2022 Direct F1
transaction REGN Common Stock Sale -$39.5K -60 -0.1% $657.51 61.8K May 17, 2022 Direct F1
transaction REGN Common Stock Sale -$81K -123 -0.2% $658.56 61.7K May 17, 2022 Direct F1
transaction REGN Common Stock Sale -$50.8K -77 -0.12% $660.32 61.6K May 17, 2022 Direct F1, F2
transaction REGN Common Stock Sale -$308K -465 -0.75% $661.46 61.2K May 17, 2022 Direct F1, F3
transaction REGN Common Stock Sale -$516K -779 -1.27% $662.57 60.4K May 17, 2022 Direct F1, F4
transaction REGN Common Stock Sale -$313K -472 -0.78% $663.60 59.9K May 17, 2022 Direct F1, F5
transaction REGN Common Stock Sale -$284K -428 -0.71% $664.32 59.5K May 17, 2022 Direct F1, F6
transaction REGN Common Stock Sale -$83.8K -126 -0.21% $665.36 59.4K May 17, 2022 Direct F1
transaction REGN Common Stock Sale -$235K -352 -0.59% $666.23 59K May 17, 2022 Direct F1, F7
transaction REGN Common Stock Sale -$103K -154 -0.26% $667.49 58.9K May 17, 2022 Direct F1, F8
transaction REGN Common Stock Sale -$120K -180 -0.31% $668.68 58.7K May 17, 2022 Direct F1, F9
transaction REGN Common Stock Sale -$102K -153 -0.26% $669.12 58.5K May 17, 2022 Direct F1, F10
transaction REGN Common Stock Sale -$38.2K -57 -0.1% $670.49 58.5K May 17, 2022 Direct F1
holding REGN Common Stock 4.29K May 16, 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10K -33.33% $0.00 20K May 16, 2022 Common Stock 10K $179.13 Direct F1, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 77 shares of Company stock on May 17, 2022 at prices ranging from $660.18 to $660.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 465 shares of Company stock on May 17, 2022 at prices ranging from $661.16 to $661.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
F4 Represents volume-weighted average price of sales of 779 shares of Company stock on May 17, 2022 at prices ranging from $662.29 to $662.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
F5 Represents volume-weighted average price of sales of 472 shares of Company stock on May 17, 2022 at prices ranging from $663.20 to $663.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
F6 Represents volume-weighted average price of sales of 428 shares of Company stock on May 17, 2022 at prices ranging from $664.01 to $664.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
F7 Represents volume-weighted average price of sales of 352 shares of Company stock on May 17, 2022 at prices ranging from $666.11 to $666.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
F8 Represents volume-weighted average price of sales of 154 shares of Company stock on May 17, 2022 at prices ranging from $667.27 to $667.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
F9 Represents volume-weighted average price of sales of 180 shares of Company stock on May 17, 2022 at prices ranging from $668.41 to $668.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
F10 Represents volume-weighted average price of sales of 153 shares of Company stock on May 17, 2022 at prices ranging from $669.00 to $669.21. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
F11 The stock option award vests in four equal annual installments, commencing one year after the date of grant.